Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain

Journal of the Neurological Sciences

Volumn 144, Issue 1-2, 1996, Pages 119-127

  Parker, Rachel M C ^a   Barnes, Janine M ^a   Ge, Jian ^a   Barber, Peter C ^a   Barnes, Nicholas M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

5 HT3 receptor; 3H (S) zacopride; caudate putamen; chemoreceptor trigger zone; hippocampus; receptor autoradiography

Indexed keywords

GRANISETRON; SEROTONIN 3 RECEPTOR; TRITIUM; ZACOPRIDE; BENZAMIDE DERIVATIVE; DIAGNOSTIC AGENT; FUSED HETEROCYCLIC RINGS; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN HOMOGENATE; DRUG RECEPTOR BINDING; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PUTAMEN; RECEPTOR DENSITY; BRAIN STEM; FOREBRAIN; METABOLISM; MIDDLE AGED; RADIOASSAY;

ADULT; AGED; AUTORADIOGRAPHY; BENZAMIDES; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN STEM; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSENCEPHALON; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; TRITIUM;

EID: 0030299837     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00211-0     Document Type: Article

References (39)

1. 3 receptors in schizophrenia: a postmortem study of the amygdala. Brain Res. 616:1993;53-57.
2. 3H]LY278584 binding sites in human brain. J. Neurochem., 60: 730-37.
3. Andrews, P.L.R., Rapeport, W.G., Sanger, G.J. (1988) Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol. Sci., 9: 334-41.
4. 3 recognition sites in the ferret area postrema. J. Pharm. Pharmacol., 40: 586-88.
5. 3 recognition sites in human brain tissue. J. Neurochem., 53: 1787-93.
6. 3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature, 338: 762-63.
7. 3H]-(S)-zacopride in the forebrain of the rat. Neuropharmacology, 29: 1037-45.
8. 3 receptor recognition sites in Alzheimer's disease. NeuroReport, 1: 253-54.
9. 3 antagonists in neuropsychiatric disorders. CNS Drugs, 3: 363-92.
10. 3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs. Br. J. Pharmacol., 101: 448-52.
11. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principal of protein dye binding. Anal. Biochem. 72:1976;248-254.
12. 3 receptor in the human forebrain. Neuropharmacology, 32: 1325-31.
13. 3 antagonist on drug-induced stimulation of dopamine release. Eur. J. Pharmacol., 164: 515-19.
14. Corradetti, R., Ballerini, L., Pugliese, A.M., Pepeu, G. (1992) Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience, 46: 511-18.
15. 3 Receptors in the Rat Brain Using [H-3]LY278584. Brain Res. 553:1991;149-154.
16. 3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci. Lett., 101: 214-17.
17. Jacobsen M.B.J. Ondansetron in carcinoid syndrome. Lancet. 340:1992;185.
18. 3 receptor recognition sites in the marmoset brain. Eur. J. Pharmacol. 215:1992;63-68.
19. Joslyn A.F. Ondansetron, clinical development for postoperative nausea and vomiting - current studies and future directions. Anaesthesia. 49:1994;34-37.
20. 3 receptors in rat brain using radioligand binding. Nature, 330: 746-48.
21. 3H]GR65630 in rat brain using quantitative autoradiography. Neurosci. Lett. 94:1989;156-160.
22. 3H]GR65630, to rat area postrema, vagus nerve and the brain of several species. Eur. J. Pharmacol., 159: 157-64.
23. 3 receptor. Biochem. Soc. Trans., 20: 118-21.
24. 3 receptors in the induction of LTP in mossy fibre-CA3 system of guinea-pig hippocampal slices. Neurosci. Res., 18: 277-82.
25. Maura, G., Andrioli, G.C., Cavazzani, P., Raiteri, M. (1992) 5-Hydroxytryptamine(3) receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release. J. Neurochem., 58: 2334-37.
26. 3 receptor in pig forebrain. Br. J. Pharmacol. 114(suppl.):1995;377P.
27. 3 receptors of the rat, mouse and guinea-pig superior cervical ganglion may be different. Br. J. Pharmacol., 102: 615-20.
28. Passani M.B., Pugliese A.M., Azzurrini M., Corradetti R. Effects of DAU 6125, a novel 5-hydroxytryptamine(3) (5-HT(3)) antagonist on electrophysiological properties of the rat hippocampus. Br. J. Pharmacol. 112:1994;695-703.
29. 3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat. Eur. J. Pharmacol. 230:1993;63-68.
30. 3H]quipazine in rodent brain. Eur. J. Pharmacol. 187:1990;75-85.
31. Plosker, G.L., Goa, K.L. (1991) Granisetron - a review of its pharmacological properties and therapeutic uses as an antiemetic. Drugs, 42: 805-24.
32. 3 receptors in mammalian hindbrain - a consensus. Trends Pharmacol. Sci., 1990; 11: 135-37.
33. 3 receptor binding sites in human dorsal vagal complex. Eur. J. Pharmacol., 174: 127-30.
34. 3 antagonists in postoperative nausea and vomiting. Br. J. Anaesth. 69(suppl 1):1992;S63-S68.
35. 3 receptor recognition sites in the putamen of patients with Huntington's disease. Eur. J. Pharmacol., 242: 137-43.
36. 3H]meta-chlorophenylbiguanide. Eur. J. Pharmacol. 243:1993;13-18.
37. Uetz, P.; Abdelatty, F., Villarroel, A., Rappold, G., Weiss, B., Koenen, M. (1994) Organisation of the murine 5-HT3 receptor gene and assignment to human chromosome 11. FEBS Lett., 339: 302-6.
38. 3H]ICS 205-930. Neuroscience. 31:1989;393-400.
39. 3 receptors attenuates the effects of ethanol on extracellular dopamine, Eur. J. Pharmacol., 187: 287-89.